Stay updated on Pembrolizumab and Binimetinib in TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Binimetinib in TNBC Clinical Trial page.

Latest updates to the Pembrolizumab and Binimetinib in TNBC Clinical Trial page
- Check4 days agoChange DetectedAdded a dedicated Locations section featuring a Florida site and updated the labeling from 'Florida Locations' to a general 'Locations' heading. Removed the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedMinor site revision from v3.2.0 to v3.3.2; no impact on study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedNotice about government funding updates and NIH operating status was removed from the page.SummaryDifference0.4%

- Check55 days agoChange DetectedThe changes appear non-significant; only formatting/UI adjustments and updated Study Record Dates are apparent, and core content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%

- Check90 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Binimetinib in TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Binimetinib in TNBC Clinical Trial page.